Evidence map›Paper›PMID 38202589›Full record

ReviewMolecules (Basel, Switzerland)2023

Recent Investigations on the Use of Copper Complexes as Molecular Materials for Dye-Sensitized Solar Cells.

Francesco Fagnani, Alessia Colombo, Claudia Dragonetti, Dominique Roberto

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Francesco FagnaniDepartment of Chemistry, University of Milan, UdR-INSTM of Milan, Via C. Golgi 19, I-20133 Milan, Italy.ORCID 0000-0002-3425-6106
Alessia ColomboDepartment of Chemistry, University of Milan, UdR-INSTM of Milan, Via C. Golgi 19, I-20133 Milan, Italy.ORCID 0000-0001-8004-3200
Claudia DragonettiDepartment of Chemistry, University of Milan, UdR-INSTM of Milan, Via C. Golgi 19, I-20133 Milan, Italy.ORCID 0000-0002-0106-0860
Dominique RobertoDepartment of Chemistry, University of Milan, UdR-INSTM of Milan, Via C. Golgi 19, I-20133 Milan, Italy.ORCID 0000-0001-9659-4760

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three decades ago, dye-sensitized solar cells (DSSCs) emerged as a route for harnessing the sun's energy and converting it into electricity. Since then, an impressive amount of work has been devoted to improving the global photovoltaic efficiency of DSSCs, trying to optimize all components of the device. Up to now, the best efficiencies have usually been reached with ruthenium(II) photosensitizers, even if in the last few years many classes of organic compounds have shown record efficiencies. However, the future of DSSCs is stringently connected to the research and development of cheaper materials; in particular, the replacement of rare metals with abundant ones is an important topic in view of the long-term sustainability of DSSCs intended to replace the consolidated fossil-based technology. In this context, copper is a valid candidate, being both an alternative to ruthenium in the fabrication of photosensitizers and a material able to replace the common triiodide/iodide redox couple. Thus, recently, some research papers have confirmed the great potential of copper(I) coordination complexes as a cheap and convenient alternative to ruthenium dyes. Similarly, the use of copper compounds as electron transfer mediators for DSSCs can be an excellent way to solve the problems related to the more common I

Indexed as

copper complexesdye-sensitized solar cellselectron shuttlesphotosensitizers

Identifiers

PMID38202589
PMCPMC10779943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.